Hoenle (HNL.DE) Stock Price

Hoenle Price

XETRA·CLOSED
8.34EUR+0.16 (+1.94 %)
Market closed

Over the last 19 years Hoenle grew revenue by 7.5% annually, reaching 93.68 M EUR. Earnings per share have grown at 0.5% per year over the last 12 years. For Hoenle, the net margin of -3.4% is broadly stable versus -4.2% a few years ago. At today's price the dividend yield works out to roughly 2.40%. The consensus 12-month price target for Hoenle is 19.38 EUR, about 132.4% above where the stock trades today. Of 6 analysts, 5 rate the stock a buy — an overall Buy consensus. The stock trades about 28% above its 52-week low.

Hoenle stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Hoenle over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Hoenle stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Hoenle's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Hoenle Stock Price History
DateHoenle Price
8/24/20268.34 EUR
8/21/20268.18 EUR
8/20/20268.12 EUR
8/19/20268.18 EUR
8/18/20268.04 EUR
8/17/20267.94 EUR
8/14/20267.90 EUR
8/13/20267.82 EUR
8/12/20267.86 EUR
8/11/20267.82 EUR
8/10/20267.90 EUR
8/7/20267.86 EUR
8/6/20267.86 EUR
8/5/20267.78 EUR
8/4/20267.84 EUR
7/31/20267.86 EUR
7/30/20267.88 EUR
7/29/20267.78 EUR
7/28/20267.72 EUR
7/27/20267.86 EUR
7/24/20267.96 EUR
7/23/20267.88 EUR
7/22/20268.08 EUR
7/21/20268.30 EUR
7/20/20268.26 EUR
7/17/20268.02 EUR
7/16/20268.52 EUR
7/15/20268.48 EUR
7/14/20268.68 EUR
7/13/20268.74 EUR
7/10/20268.88 EUR
7/9/20268.86 EUR
7/8/20268.72 EUR
7/7/20268.64 EUR
7/6/20268.50 EUR
7/3/20268.52 EUR
7/2/20268.48 EUR
7/1/20268.50 EUR
6/30/20268.56 EUR
6/29/20268.96 EUR
6/26/20269.12 EUR
6/25/20269.12 EUR
6/24/20269.16 EUR
6/23/20269.12 EUR
6/22/20269.14 EUR
6/19/20269.32 EUR
6/18/20269.32 EUR
6/17/20269.08 EUR
6/16/20269.12 EUR
6/15/20269.16 EUR
6/12/20269.38 EUR
6/11/20269.28 EUR
6/10/20269.48 EUR
6/9/20269.60 EUR
6/8/20269.48 EUR
6/5/20269.32 EUR
6/4/20269.54 EUR
6/3/20269.44 EUR
6/2/20269.66 EUR
6/1/20269.54 EUR
5/29/20269.48 EUR
5/28/20269.48 EUR
5/27/20269.48 EUR
5/26/20269.22 EUR
5/25/20269.40 EUR
5/22/20269.40 EUR
5/21/20269.44 EUR
5/20/20269.42 EUR
5/19/20269.54 EUR
5/18/20269.46 EUR
5/15/20269.54 EUR
5/14/20269.56 EUR
5/13/20269.50 EUR
5/12/20269.44 EUR
5/11/20269.40 EUR
5/8/20269.40 EUR
5/7/20269.40 EUR
5/6/20269.44 EUR
5/5/20269.56 EUR
5/4/20269.20 EUR
4/30/20268.94 EUR
4/29/20268.90 EUR
4/28/20268.92 EUR
4/27/20268.92 EUR
4/24/20268.90 EUR
4/23/20269.10 EUR
4/22/20269.12 EUR
4/21/20268.80 EUR
4/20/20269.08 EUR
4/17/20269.42 EUR
4/16/20269.28 EUR
4/15/20269.30 EUR
4/14/20269.28 EUR
4/13/20269.12 EUR
4/10/20269.24 EUR
4/9/20269.40 EUR
4/8/20269.48 EUR
4/7/20269.38 EUR
4/2/20268.46 EUR
3/27/20268.22 EUR
3/26/20268.44 EUR
3/25/20268.64 EUR
3/24/20268.52 EUR
3/23/20268.31 EUR
3/20/20269.02 EUR
3/19/20269.20 EUR
3/18/20269.42 EUR
3/17/20269.24 EUR
3/16/20269.20 EUR
3/13/20269.48 EUR
3/12/20269.50 EUR
3/11/20269.58 EUR
3/10/20269.50 EUR
3/9/20269.60 EUR
3/6/20269.44 EUR
3/5/20269.18 EUR
2/26/202610.15 EUR
2/25/20269.83 EUR
2/24/20269.78 EUR
2/23/20269.48 EUR
2/20/20268.66 EUR
2/19/20268.66 EUR
2/18/20268.66 EUR
2/17/20268.78 EUR
2/16/20268.84 EUR
2/13/20268.90 EUR
2/12/20268.86 EUR
2/11/20268.66 EUR
2/10/20268.44 EUR
2/9/20268.44 EUR
2/6/20268.62 EUR
2/4/20268.52 EUR
2/3/20269.10 EUR
2/2/20269.20 EUR
1/30/20269.30 EUR
1/29/20269.24 EUR
1/28/20269.42 EUR
1/27/20269.36 EUR
1/26/20269.34 EUR
1/23/20269.50 EUR
1/22/20269.62 EUR
1/21/20269.40 EUR
1/20/20269.38 EUR
1/19/20269.54 EUR
1/16/20269.40 EUR
1/15/20268.54 EUR
1/14/20268.34 EUR
1/13/20267.96 EUR
1/12/20268.02 EUR
1/9/20267.55 EUR
1/8/20267.34 EUR
1/7/20267.26 EUR
1/6/20267.24 EUR
1/2/20267.10 EUR
12/30/20257.08 EUR
12/29/20257.08 EUR
12/23/20257.00 EUR
12/22/20256.96 EUR
12/19/20256.78 EUR
12/18/20257.00 EUR
12/17/20256.70 EUR
12/16/20256.90 EUR
12/15/20256.98 EUR
12/12/20257.10 EUR
12/11/20257.00 EUR
12/10/20256.78 EUR
12/9/20256.86 EUR
12/8/20256.98 EUR
12/5/20257.00 EUR
12/4/20257.00 EUR
12/3/20256.98 EUR
12/2/20257.22 EUR
12/1/20257.24 EUR
11/28/20257.28 EUR
11/27/20256.82 EUR
11/26/20256.52 EUR
11/25/20256.70 EUR
11/24/20256.58 EUR
11/21/20256.64 EUR
11/20/20256.56 EUR
11/19/20256.82 EUR
11/18/20257.10 EUR
11/17/20257.28 EUR
11/14/20257.06 EUR
11/13/20257.14 EUR
11/12/20257.28 EUR
11/11/20257.36 EUR
11/10/20257.28 EUR
11/7/20257.26 EUR
11/6/20257.48 EUR
11/5/20257.50 EUR
11/4/20257.44 EUR
11/3/20257.64 EUR
10/31/20257.54 EUR
10/30/20257.92 EUR
10/29/20257.98 EUR
10/28/20257.80 EUR
10/27/20258.00 EUR
10/24/20257.98 EUR
10/23/20258.16 EUR
10/22/20258.18 EUR
10/21/20257.88 EUR
10/20/20257.90 EUR
10/17/20258.16 EUR
10/16/20258.32 EUR
10/15/20258.38 EUR
10/14/20258.40 EUR
10/13/20258.46 EUR
10/10/20258.42 EUR
10/9/20258.40 EUR
10/8/20258.48 EUR
10/7/20258.54 EUR
10/6/20258.56 EUR
10/3/20258.62 EUR
10/2/20258.60 EUR
10/1/20258.38 EUR
9/30/20258.26 EUR
9/29/20258.20 EUR
9/26/20258.50 EUR
9/25/20258.58 EUR
9/24/20258.58 EUR
9/23/20258.52 EUR
9/22/20258.76 EUR
9/19/20258.80 EUR
9/18/20258.86 EUR
9/17/20258.50 EUR
9/16/20258.52 EUR
9/15/20258.46 EUR
9/12/20258.18 EUR
9/11/20258.16 EUR
9/10/20258.22 EUR
9/9/20258.24 EUR
9/8/20257.88 EUR
9/5/20257.92 EUR
9/4/20257.98 EUR
9/3/20257.90 EUR
9/2/20258.10 EUR
9/1/20258.22 EUR
8/29/20257.88 EUR
8/28/20258.18 EUR
8/27/20258.18 EUR
8/26/20258.28 EUR
Access this data via the Eulerpool API
Get Free API Key

Hoenle Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
115.17 M EUR
349,000.00 EUR
-4.82 M EUR
Jan 1, 2022
116.09 M EUR
5.84 M EUR
-13.36 M EUR
Jan 1, 2023
106.34 M EUR
-9.42 M EUR
-11.01 M EUR
Jan 1, 2024
98.73 M EUR
-10.21 M EUR
-13.28 M EUR
Jan 1, 2025
93.68 M EUR
336,000.00 EUR
-3.17 M EUR
Jan 1, 2026 (e)
93.60 M EUR
-2.43 M EUR
-1.21 M EUR
Jan 1, 2027 (e)
102.87 M EUR
-2.68 M EUR
1.78 M EUR
Jan 1, 2028 (e)
112.70 M EUR
-2.93 M EUR
4.26 M EUR

Hoenle Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 26, 2026, 2:09 PM
 
REVENUEM EUR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM EUR
EBITM EUR
EBIT MARGIN%
NET INCOMEM EUR
NET INCOME GROWTH%
DIV.EUR
DIV. GROWTH%
SHARESM
20132014201520162017201820192020202120222023202420252026e2027e2028e
78.0082.0092.0093.00101.00126.00107.0093.00115.00116.00106.0098.0093.0093.00102.00112.00
8.335.1312.201.098.6024.75-15.08-13.0823.660.87-8.62-7.55-5.10–9.689.80
61.5463.4163.0463.4464.3636.5167.2964.5260.0059.4850.0061.2212.9012.9012.9012.90
48.0052.0058.0059.0065.0046.0072.0060.0069.0069.0053.0060.0012.0012.0013.1614.45
7.009.0013.0012.0015.0030.0017.008.00–5.00-9.00-10.00–-2.00-2.00-2.00
8.9710.9814.1312.9014.8523.8115.898.60–4.31-8.49-10.20–-2.15-1.96-1.79
6.006.0010.008.0010.0021.0012.005.00-4.00-13.00-11.00-13.00-3.00-1.001.004.00
20.00–66.67-20.0025.00110.00-42.86-58.33-180.00225.00-15.3818.18-76.92-66.67-200.00300.00
0.500.500.500.550.550.600.800.800.500.20–––0.200.200.20
–––10.00–9.0933.33–-37.50-60.00––––––
5.515.515.515.515.515.515.516.066.066.066.066.066.066.066.066.06
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Hoenle generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Hoenle retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Hoenle's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Hoenle has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Hoenle's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Hoenle stock margins

The Hoenle margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Hoenle. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Hoenle.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
60.21 %
0.30 %
-4.19 %
Jan 1, 2022
59.68 %
5.03 %
-11.51 %
Jan 1, 2023
50.17 %
-8.86 %
-10.35 %
Jan 1, 2024
60.85 %
-10.34 %
-13.45 %
Jan 1, 2025
13.32 %
0.36 %
-3.38 %
Jan 1, 2026 (e)
13.32 %
-2.60 %
-1.29 %
Jan 1, 2027 (e)
13.32 %
-2.60 %
1.73 %
Jan 1, 2028 (e)
13.32 %
-2.60 %
3.78 %

Hoenle Stock Revenue, EBIT, Earnings per Share

The Hoenle earnings per share therefore indicates how much revenue Hoenle has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
19.00 EUR
0.06 EUR
-0.80 EUR
Jan 1, 2022
19.15 EUR
0.96 EUR
-2.20 EUR
Jan 1, 2023
17.54 EUR
-1.55 EUR
-1.82 EUR
Jan 1, 2024
16.29 EUR
-1.68 EUR
-2.19 EUR
Jan 1, 2025
15.45 EUR
0.06 EUR
-0.52 EUR
Jan 1, 2026 (e)
15.45 EUR
-0.40 EUR
-0.20 EUR
Jan 1, 2027 (e)
16.97 EUR
-0.44 EUR
0.29 EUR
Jan 1, 2028 (e)
18.60 EUR
-0.48 EUR
0.70 EUR

Hoenle business model & stock analysis

The Dr Hoenle AG is a traditional company specializing in the production and distribution of UV systems, industrial drying systems, adhesives, and coating systems. It was founded in 1972 by Dr. Rolf Hoenle in Gräfelfing near Munich and has an international customer base. The history of Dr Hoenle AG began in the 1960s when Dr. Hoenle recognized the importance of UV technology for the industry and intensified his research in this area. In the 1970s, the company built its first UV exposure systems and thus developed into a leading manufacturer of UV systems. Dr Hoenle AG has divided its activities into various divisions. The UV Technology and Process Engineering department specializes in the production of UV systems. The UV systems are used in various industries, such as the paint, coating, automotive, paper, and printing industries. The UV systems can be used for curing coatings, disinfecting surfaces, and drying paints and varnishes. The industrial drying systems division specializes in the design and construction of drying systems for materials. The drying systems are used, among other things, in the textile industry, packaging and label printing, and food processing. The Adhesives and Coating Systems department produces innovative adhesives and coatings for various applications. The products are used, for example, in the automotive and electronics industries, as well as in construction and furniture manufacturing. Dr Hoenle AG has a wide range of products in its portfolio. The UV systems are available in various designs and sizes and can be customized to meet the individual needs of customers. The industrial drying systems are available in various designs, such as through-feed systems or tunnel systems. The adhesive and coating-based products are characterized by their high quality and long-term stability. The business model of Dr Hoenle AG is based on the production of innovative products that are produced to the highest quality standards. The products are characterized by reliability, durability, and functionality. The company has extensive experience in the development of solutions and technologies and is therefore often chosen as a competent and reliable partner. The products are distributed internationally and customers can be found all over the world. Dr Hoenle AG has set itself the goal of constantly developing its products and technologies to meet the needs of customers. To achieve this, the company invests high amounts in research and development every year. Dr Hoenle AG also operates its own research laboratory and is constantly striving to drive forward new solutions and applications in various industries. In summary, Dr Hoenle AG is a renowned company with extensive experience in its industry. The company produces high-quality products and offers innovative solutions for a wide range of applications and industries. Thanks to research and development and the relentless search for new solutions, Dr Hoenle AG will also maintain its position as a leading company in global markets in the future.

Hoenle SWOT Analysis

Strengths

Dr Hoenle AG has several notable strengths that contribute to its success in the market. These strengths include:

  • Strong brand reputation and recognition
  • Extensive experience in the industry
  • Comprehensive product portfolio with high-quality offerings
  • Advanced technology and innovation capabilities
  • Efficient supply chain management
  • Skilled and dedicated workforce

Weaknesses

Despite its strengths, Dr Hoenle AG also faces certain weaknesses that need to be addressed in order to maintain its competitive position:

  • Reliance on a limited number of key customers
  • High production costs
  • Dependency on specific suppliers
  • Inadequate presence in certain geographic markets
  • Limited brand awareness outside of the industry

Opportunities

Despite the weaknesses, Dr Hoenle AG can capitalize on various opportunities in the market:

  • Expansion into emerging markets with high growth potential
  • Development of new and innovative products
  • Increasing demand for environmentally friendly solutions
  • Strategic partnerships and collaborations
  • Growing emphasis on automation and digitalization

Threats

Dr Hoenle AG faces certain threats that can hinder its growth and profitability:

  • Intense competition from both established and emerging players
  • Economic downturns and market uncertainties
  • Changes in regulations and compliance requirements
  • Rapid technological advancements leading to product obsolescence
  • Fluctuating raw material prices

Hoenle Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Hoenle historical P/E ratio, EBIT multiple, and P/S ratio

Hoenle annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Hoenle shares outstanding

The number of shares of Hoenle was 6.06 M in 2025. This indicates how many shares Hoenle is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
6.06 M Stocks
Jan 1, 2022
6.06 M Stocks
Jan 1, 2023
6.06 M Stocks
Jan 1, 2024
6.06 M Stocks
Jan 1, 2025
6.06 M Stocks
Jan 1, 2026 (e)
6.06 M Stocks
Jan 1, 2027 (e)
6.06 M Stocks
Jan 1, 2028 (e)
6.06 M Stocks

Hoenle Dividend History

19 years of dividend payments

YearAnnual DividendYoY ChangePayments
20220.20EUR↓ 60.0%1×
20210.50EUR↓ 37.5%1×
20200.80EUR 0.0%1×
20190.80EUR↑ 33.3%1×
20180.60EUR↑ 9.1%1×
20170.55EUR 0.0%1×
20160.55EUR↑ 10.0%1×
20150.50EUR 0.0%1×
20140.50EUR 0.0%1×
20130.50EUR 0.0%1×

Hoenle dividend payout ratio

In 2025, Hoenle had a payout ratio of 62.03%. The payout ratio indicates the percentage of the company's profits that Hoenle distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
-62.88 %
Jan 1, 2022
-9.07 %
Jan 1, 2023
45.32 %
Jan 1, 2024
55.36 %
Jan 1, 2025
62.03 %
Jan 1, 2026 (e)
54.24 %
Jan 1, 2027 (e)
68.18 %
Jan 1, 2028 (e)
28.44 %

Current Hoenle forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
11.76 %
Buy
83.33 % (5)
Hold
16.67 % (1)
Sell
0.00 % (0)
12M Price Target
19.38
Last Price
8.34
Currency
EUR
12M Return Potential
132.37 %
LTM Return
0 %

EESG©

Eulerpool ESG Scorecard© for the Hoenle stock

44/100
37
Environment
71
Social
24
Governance
E

Environment

20
Scope 1 - Direct Emissions257.22
Scope 2 - Indirect emissions from purchased energy568.21
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions825.43
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees32
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Hoenle shareholder structure

% Name
25.41228%
34. PMB Management GmbH
34. PMB Management GmbH
4.20203%
Vits (Dr. Hans-Joachim)
Vits (Dr. Hans-Joachim)
4.20203%
Lazard Frères Gestion S.A.S.
Lazard Frères Gestion S.A.S.
2.88779%
Quaero Capital S.A.
Quaero Capital S.A.
2.70130%
Richter (Franz)
Richter (Franz)
1.10053%
Dimensional Fund Advisors, L.P.
Dimensional Fund Advisors, L.P.

Hoenle Beneficial Ownership Filings (SEC 13D/G)

Free Float
64.7%
Float Shares
-
Shares Outstanding
-

Hoenle Executives and Management Board

7 members · avg. age 60 · 29 % women

Management

RS

Mr. Robert Stark

Chief Financial Officer, Member of the Management Board

–
DW

Dipl.-Kfm. Peter Weinert

Investor Relations Manager

–

Board of Directors

FR

Dr. Franz Richter (70)

Member of the Management Board · since 2023

25.21 M EUR
NF

Mr. Niklas Friedrichsen (59)

Independent Member of the Supervisory Board · since 2022

48,000.00 EUR
BG

Dr. Bernhard Gimple (55)

Independent Vice Chairman of the Supervisory Board · since 2015

38,000.00 EUR
PL

Prof. Dr. Imke Libon (54)

Independent Member of the Supervisory Board

30,000.00 EUR
MO

Ms. Melanie Ott

Independent Member of the Supervisory Board

15,000.00 EUR

Hoenle Supply Chain

Hoenle Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
1 companies
#NameTrend
1
MLS A
Supplier·Customer·Semiconductors & Semiconductor Equipment·CN
-0.48
-0.51
0.73
0.89
0.74
0.54

Frequently asked questions about Hoenle

The business model of Dr Hoenle AG revolves around providing innovative UV technology solutions. As a leading manufacturer of UV systems, the company offers a wide range of products and services. Dr Hoenle AG specializes in developing and producing UV lamps, LED modules, and systems for various industries like automotive, printing, and electronics. With a focus on sustainability and energy efficiency, they deliver high-quality and reliable solutions for curing, bonding, and disinfection applications. Dr Hoenle AG also offers customer-specific solutions along with comprehensive technical support, ensuring their clients' needs are met effectively.

Dr Hoenle AG is primarily active in the fields of adhesives, coatings, and surface technology.

Dr Hoenle AG faces competition from various companies in the market. Some of its main competitors include UV technology providers such as IST METZ GmbH, Heraeus Noblelight GmbH, and Phoseon Technology. These competitors also specialize in manufacturing UV curing systems, UV lamps, and UV LED products. Furthermore, Dr Hoenle AG also contends with other companies involved in industrial adhesives, coatings, and printing industries. Being a leader in UV technology and offering innovative solutions, Dr Hoenle AG strives to maintain its competitive advantage and cater to the diverse needs of its customers.

Dr Hoenle AG is a German technology company specializing in UV technology and industrial adhesives. Founded in 1972 by Dr. Hans Hoenle, the company has an extensive history in providing innovative solutions for various industries. Dr Hoenle AG has established itself as a leader in the field of UV curing technology, offering products such as UV lamps, LED curing systems, and UV adhesives. With a commitment to research and development, the company has continuously improved its products, expanding its global presence and serving customers worldwide. Dr Hoenle AG's dedication to technological advancement and customer satisfaction has made it a trusted brand in the industry.

Dr Hoenle AG, a leading company in its industry, has achieved several significant milestones. The company's commitment to innovation and quality has allowed it to establish a strong presence in the market. Dr Hoenle AG has successfully expanded its product portfolio, offering advanced solutions tailored to various sectors. Furthermore, the company has secured numerous patents, demonstrating its dedication to research and development. Dr Hoenle AG's consistent growth and profitability have been instrumental in establishing its reputation as a reliable and successful player in the industry. As a result of these achievements, the company continues to attract investors and maintain its position as a market leader.

Dr Hoenle AG is primarily present in Germany, where its headquarters are located. Additionally, the company operates globally and has a significant presence in various countries and regions worldwide. With its advanced technologies and high-quality products, Dr Hoenle AG serves customers across Europe, especially in countries like Austria, Switzerland, and France. The company also has a significant presence in North America, catering to customers in the United States and Canada. Overall, Dr Hoenle AG has established itself as a prominent player in the global market, offering innovative solutions and meeting the needs of customers in multiple countries and regions.

Dr Hoenle AG represents values and a corporate philosophy centered on innovation, quality, and sustainability. As a leading company in the field of industrial UV technology, Dr Hoenle AG consistently strives to deliver cutting-edge solutions that meet the highest standards. The company is committed to creating sustainable products and processes, ensuring responsible resource management and minimizing its ecological footprint. With a focus on customer satisfaction, Dr Hoenle AG aims to provide reliable and efficient solutions that contribute to the success and growth of its clients. By continuously investing in research and development, Dr Hoenle AG remains at the forefront of technological advancements, delivering value to its stakeholders and maintaining a strong market presence.

Analysts currently set an average price target of 18.36 EUR for the Hoenle stock (median: 19.38 EUR), implying +120.1 % versus the latest price. The consensus is based on 6 analyst ratings.

Hoenle Analyst Price Targets 2026

7 analysts currently rate the Hoenle stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Hoenle to generate revenue of 93.60 M EUR and earnings per share of -0.20 EUR.

Hoenle Analyst Price Targets 2026

The Hoenle share (HNL.DE) is listed on 8 stock exchanges, including: XETRA (HNL.DE), Frankfurt (HNL.F), München (HNL.MU), Düsseldorf (HNL.DU), Hamburg (HNL.HM), London (0O27.L), London (0O27.L), SIX (Zürich) (HNL.SW).

Dr Hoenle AG is an internationally leading provider of UV technology for industrial applications. The company was founded in 1972 and is headquartered in Gräfelfing near Munich. With around 600 employees and a turnover of almost 100 million euros, the company is a significant player in its field. The business model of Dr Hoenle AG is based on the development, production, and sale of UV technology for a variety of applications. The company offers a wide range of products, divided into three divisions: UV technology for surface disinfection, industrial applications, and 3D printing. The first division includes products for surface disinfection, which are mainly used in medical facilities and the food industry. For example, this includes UV-C devices for air disinfection and surface sterilization. These devices are in high demand during the COVID-19 pandemic, as they effectively act against viruses and bacteria. The second division is the industrial application of UV technology. Here, Dr Hoenle offers a variety of products that can be used in different industries. This includes UV dryers for the printing industry, UV adhesives for automotive construction, and UV coatings for surfaces. The third division is 3D printing, for which Dr Hoenle has developed special UV-LED systems. These enable fast and precise curing of resins used in additive manufacturing. The applications range from prototype production to the production of series components. The business model of Dr Hoenle AG is based on a strong research and development department as well as close cooperation with customers from various industries. The company focuses on continuous innovation and aims to improve the efficiency and sustainability of industrial processes. In order to successfully implement the business model, the company relies on an international orientation. Dr Hoenle is represented in over 60 countries worldwide and operates its own sales and service companies in Europe, Asia, and the USA. In summary, Dr Hoenle AG is an innovative company specializing in UV technology for a variety of applications. The wide product range includes products for surface disinfection, industrial applications, and 3D printing. The business model is based on strong research and development, international orientation, and close cooperation with customers from various industries.

The expected revenue of Hoenle is 93.60 M EUR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Hoenle is -1.21 M EUR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Hoenle is currently -41.71. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Hoenle stock.

The price-to-sales ratio (P/S) of Hoenle is currently 0.54. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Hoenle stock.

The Eulerpool Quality Score for Hoenle is 0/10.

The ISIN of Hoenle is DE0005157101. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Hoenle is 515710. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Hoenle is HNL.DE. The ticker symbol is used to trade Hoenle shares on the stock exchange.

Over the past 12 months, Hoenle paid a dividend of 0.20 EUR . This corresponds to a dividend yield of about 2.40 %. For the coming 12 months, Hoenle is expected to pay a dividend of 0.20 EUR.

The current dividend yield of Hoenle is 2.40 %.

Hoenle pays a dividend, distributed in the months of , , , .

Hoenle paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 0.20 EUR are expected. This corresponds to a dividend yield of 2.40 %.

Hoenle is assigned to the 'Industry' sector.

To receive the latest dividend of Hoenle from amounting to 0.2 EUR, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

The dividends of Hoenle are distributed in EUR.

All fundamentals and in-depth analysis of Hoenle

Our stock analysis for Hoenle stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hoenle. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Hoenle Stock
Hoenle Revenue→
Hoenle Stock
Hoenle Net Income→
Hoenle Stock
Hoenle P/E→
Hoenle Stock
Hoenle P/S→
Hoenle Stock
Hoenle EBIT→
Hoenle Stock
Hoenle Dividend→
Hoenle Stock
Hoenle Directors Dealings→
Hoenle Stock
Hoenle Stocks→
Hoenle Stock
Hoenle Market capitalization→
Hoenle Stock
Hoenle Debt→
Hoenle Stock
Hoenle Liabilities→
Hoenle Stock
Hoenle Equity→
Hoenle Stock
Hoenle AAQS→
Hoenle Stock
Hoenle Employees→
Hoenle Stock
Hoenle ROE→
Hoenle Stock
Hoenle ROA→
Hoenle Stock
Hoenle ROCE→
Hoenle Stock
Hoenle News→
Hoenle Stock
Hoenle Analyst Price Targets→

Industry Stocks

Hoffmen Cleanindo PT TbkHoe Leong CorporationHojogumi CoHoden Seimitsu Kako Kenkyusho CoHokuHock Lian Seng HoldingsHokuriku Electrical Construction CoHochtiefHold-Key Electric Wire & Cable CoHochengHollund Industrial MarineHoang Huy Investment Services JSCAll Stocks A–Z →